How does Lilly’s next-gen obesity drug compare to Novo’s

Goldmoney reports FY results

2026/06/22

NVE announces internal CEO transition as Daniel Baker nears retirement

2026/06/22

Invesco S&P International Developed Low Volatility ETF declares distribution

2026/06/22

Alimentation Couche-Tard Non-GAAP EPS of $0.73, revenue of $19.49B

2026/06/22